Once viewed primarily as weight loss and diabetes drugs, GLP-1 medications are drawing increased scrutiny in oncology. Leaders are beginning to examine what the drugs could mean for cancer risk and outcomes, as a growing body of research suggests the…
The Latest
Naples (Fla.) Comprehensive Health has received $10 million to support women’s cancer care services. The gift will fund services across multiple NCH facilities, including an outpatient infusion center and the women’s oncology surgical wing at NCH North Hospital, according to…
Adults younger than 65 now account for 45% of all newly diagnosed colorectal cancer cases in the U.S., up from 27% in 1995, according to the American Cancer Society’s “Colorectal Cancer Statistics, 2026” report published March 2 in CA: A…
Stanford (Calif.) Cancer Institute has tapped Vivek Subbiah, MD, as inaugural associate director for drug development and precision oncology. Dr. Subbiah was also appointed as executive medical director for cancer novel therapies and clinical trial network development at Stanford (Calif.)…
For decades, oncology programs have measured success by volume, speed and five-year survival rates. Ten cancer leaders told Becker’s these benchmarks are increasingly disconnected from what matters most: timely, equitable access to evidence-based treatment and outcomes that reflect both survival…
Starting specialty therapy can involve navigating as many as nine separate platforms.For health systems, medical centers and hospital pharmacies, that fragmentation slows treatment initiation and complicates coordination across stakeholders. In oncology, even small delays can carry significant clinical and operational…
Apr 1, 2026 11:00 PM - 12:00 PM CDT
Presented by:
Presenters:
- Miranda Delatore, DNP, RN, NEA-BC, Vice President, Product, CoverMyMeds
- Molly M. Brady, RN, BSN, Director of Customer Success, Ontada
- Jakob Emerson, Managing Editor, Becker’s Healthcare
A team from the University of California San Diego has collaborated on the development of an AI model to improve the precision of prostate cancer radiation therapy. The AI tool matched or outperformed human experts at mapping the urethra on…
Co-located multidisciplinary clinics — where newly diagnosed cancer patients meet with all of their cancer specialists on the same day — can expedite time to treatment, reduce costs and improve outcomes, according to a study published Feb. 20 in the…
Behavioral health can no longer function as a crisis-only service line. Health systems are confronting the limits of episodic models that intervene too late, fragment care and strain emergency departments. As value-based expectations grow, leaders are redesigning behavioral health to…
Mar 24, 2026 1:00 PM - 2:00 PM CDT
Presented by:
Presenters:
- Scott Domingue, DNP, MBA, RN, NEA-BC, Chief Operating Officer and Chief Nursing Officer, Texas Health Resources
- Tami Lew-Ahrendt, MA CCT, PHR, SHRM-CP, President and Chief Executive Officer, CenterPointe
- Laura Bauer, VP Strategy, Iris Telehealth
A team at Philadelphia-based Fox Chase Cancer Center has developed a patient education program aimed at improving clinical trial enrollment. The multidisciplinary team created the program after interviewing and collaborating with kidney cancer patients, according to a Feb. 26 news…